公司資料
MorphoSys 股價、新聞與催化劑
- 股票代碼:
- MOR
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- Germany and listed in the U
股價為何變動
Current closing-price context is not available for MOR.
公司概覽
業務概覽
MorphoSys was a German antibody biotechnology company focused on oncology and immunology before its acquisition by Novartis. Its legacy value came from antibody discovery and partnered programs.
所在地與產業分類
Headquartered in Germany and listed in the U.S. as an ADR before acquisition, MorphoSys was a global antibody-biotech name.
商業模式特徵
The business relied on partnered assets, royalties, and internal oncology development rather than a broad commercial base.
生技產業定位
MorphoSys was a premium antibody platform name and now belongs to biotech M&A history.
未來催化劑
- MorphoSys is now mostly a closeout story, so the catalysts are any remaining value-realization or legacy-asset update rather than a fresh pipeline milestone. The market is focused on what residual value is left.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。